GSK Consumer Healthcare
Brands
Class-Action Tracker
Tylenol, Theraflu, NyQuil, and DayQuil
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Children’s Dimetapp, DayQuil, Mucinex, Mucinex Children’s, and Sudafed
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
NyQuil, Tylenol, Sudafed, Mucinex, and Several Store Brands
Allegations: Falsely marketing that medicines treat nasal congestion
Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines
Allegations: Falsely marketing that medicines are decongestants
Cold and Flu Medicines
Allegations: Falsely marketing the products treat nasal congestion
Several Brands of Cold and Flu Medicines
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Alka-Seltzer, Theraflu, Rite Aid, and Walgreens Cold and Flu Medicines
Allegations: Falsely marketing that medicines treat nasal congestion
DayQuil, NyQuil, and Theraflu
Allegations: Falsely marketing that medicines treat nasal congestion
Emergen-C Raspberry Daily Immune Support Dietary Supplement
Allegations: Misleadingly marketing drink mixes using the phrase “Natural fruit flavor” and images of raspberries when they contain artificial flavoring ingredients
TheraFlu Emergen-C and TheraFlu Multi-Symptom Severe Cold
Allegations: Misleadingly marketing products as if they treat symptoms of coughs and colds
Benefiber Prebiotic Powders
Allegations: False natural claims
Benefiber Fiber Supplements
Allegations: False natural claims
Benefiber Prebiotic Powder
In November 2020, a class-action lawsuit was filed against GSK Consumer Health for allegedly falsely advertising Benefiber prebiotic powders as “100% Natural” when, according to plaintiffs, the powders contain wheat…
Benefiber Prebiotic Supplement
In August 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare for allegedly misleadingly advertising Benefiber Prebiotic Supplement as “100% Natural” when, according to plaintiffs, the company uses a…